Intellectual Property India Publishes Patent Application for '1,4-Dihydroquinazolinone Compounds And Uses Thereof' Filed by Edgewise Therapeutics, Inc.

MUMBAI, India, May 2 -- Intellectual Property India has published a patent application (202517025982 A) filed by Edgewise Therapeutics, Inc., Boulder, U.S.A., on March 21, for '1,4-dihydroquinazolinone compounds and uses thereof.'

Inventor(s) include Hawryluk, Natalie; Schlachter, Stephen; Evanchik, Marc; Del Rio, Carlos; Russell, Alan; Koch, Kevin; Duvall, Michael; Luzzio, Michael; and Hunt, Kevin.

The application for the patent was published on May 2, under issue no. 18/2025.

According to the abstract released by the Intellectual Property India: "Provided dihydroquinazolinone and azadihydroquinazolinone compounds for treating cardiac indications such as hypertrophic cardiomyopathy and diastolic dysfunction."

The patent application was...